📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Captozyme

1.1 - Company Overview

Captozyme Logo

Captozyme

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapeutic enzyme-based biotechnology products for health and wellness, dedicated to helping people better manage diets and overall health. Developing Nephure, a product that enables people to enjoy foods they love without adding oxalate to their bodies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Captozyme

ViaCyte Logo

ViaCyte

HQ: United States Website
  • Description: Provider of preclinical regenerative medicine therapies for diabetes, based on differentiation of stem cells into pancreatic beta-cell precursors implanted subcutaneously in an encapsulation device.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ViaCyte company profile →
MRM Health Logo

MRM Health

HQ: Belgium Website
  • Description: Provider of microbiome-based therapeutics and development platforms, including the CORAL platform to design optimized microbial consortia, SHIME simulator of the human gut, and Optimized Consortia therapeutics. Offers clinical programs in inflammatory bowel diseases (Ulcerative Colitis, Pouchitis) with MH002, and preclinical programs in CNS, metabolic (Type 2 Diabetes, NAFLD/NASH) and auto-immune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MRM Health company profile →
Ysopia Bioscience Logo

Ysopia Bioscience

HQ: France Website
  • Description: Provider of cutting-edge microbiome-based biotherapies in clinical-stage development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ysopia Bioscience company profile →
HepaRegeniX Logo

HepaRegeniX

HQ: Germany Website
  • Description: Provider of drug candidates targeting MKK4 to restore hepatocyte regeneration for acute and chronic liver diseases. Pipeline includes HRX-0215, a first-in-class MKK4 inhibitor in clinical trials, and HRX-0233, a second MKK4 inhibitor under preclinical collaborations for cancer combination therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HepaRegeniX company profile →
Ilypsa Logo

Ilypsa

HQ: United States Website
  • Description: Provider of renal care pharmaceutical products, discovering, developing, manufacturing, and delivering human therapeutics, including non-absorbed polymeric phosphate and potassium binder compounds to treat chronic kidney diseases. Formerly known as Symyx Therapeutics, Inc., founded in 2002 and based in Santa Clara, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ilypsa company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Captozyme

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Captozyme

2.2 - Growth funds investing in similar companies to Captozyme

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Captozyme

4.2 - Public trading comparable groups for Captozyme

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Captozyme

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Captozyme

What does Captozyme do?

Captozyme is a provider of therapeutic enzyme-based biotechnology products for health and wellness, dedicated to helping people better manage diets and overall health. Developing Nephure, a product that enables people to enjoy foods they love without adding oxalate to their bodies.

Who are Captozyme's competitors?

Captozyme's competitors and similar companies include ViaCyte, MRM Health, Ysopia Bioscience, HepaRegeniX, and Ilypsa.

Where is Captozyme headquartered?

Captozyme is headquartered in United States.

How many employees does Captozyme have?

Captozyme has 1,000 employees 🔒.

When was Captozyme founded?

Captozyme was founded in 2010 🔒.

What sector and industry vertical is Captozyme in?

Captozyme is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Captozyme

Who are the top strategic acquirers in Captozyme's sector and industry

Top strategic M&A buyers and acquirers in Captozyme's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Captozyme?

Top strategic M&A buyers groups and sectors for Captozyme include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Captozyme's sector and industry vertical

Which are the top PE firms investing in Captozyme's sector and industry vertical?

Top PE firms investing in Captozyme's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Captozyme's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Captozyme's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Captozyme's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Captozyme include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Captozyme's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Captozyme?

The key public trading comparables and valuation benchmarks for Captozyme include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Captozyme for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Captozyme with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Captozyme's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Captozyme with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Captozyme's' sector and industry vertical?

Access recent funding rounds and capital raises in Captozyme's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Captozyme